Sponsored Article

Nuveen: Drilling down with data to the local level

A data-led approach to global cities highlights growing populations, new industries and forward-thinking city governments, says Nuveen’s Donald Hall.

Alter Domus on maximizing technology capabilities to enhance decision-making

Technology is part of a solution that involves bringing together managers, investors and back-office administrators to make better decisions and improve investment performance, says Gus Harris, head of data and analytics at Alter Domus.

Edmond de Rothschild: Granularity is the trend in fast-changing cities

Logistics and light industrial investments are playing a role in evolving urban cityscapes, says Edmond de Rothschild’s Theo Soeters.

Arrow Global reveals the recipe for lasting business success

Embracing DE&I policies has the potential to generate stronger risk-adjusted returns for investors, according to Arrow Global’s Jan Wade.

Roundtable: US investors still hesitant amid ‘shell shock’

Investment activity has not rebounded despite flattening interest rates and strong economic indicators, say PERE’s US roundtable participants.

Yardi on fulfilling AI’s potential

Technological developments in commercial real estate are offering a dizzying range of operational benefits for investors willing to take the plunge, says Yardi’s Rob Teel.

Roundtable: US lenders tackle the ‘higher for longer’ puzzle

Interest rate increases have raised credit spreads but reduced dealflow in the US. Real estate lenders say it is time for buyers and sellers to have a meeting of minds to reactivate the market.

Actis: Hyperscalers are transforming the landscape

The needs of the largest companies are changing the market for investors and driving sustainability, says Actis’s Dalmar Sheikh.

Keppel: Asia is ‘ready to leap forward’ on data center development

With a huge runway for growth driven by AI, the hyperscale campus format is the future, explain Keppel’s Wai Meng Wong and Hwee Long Loh.

CBC: Demographics drive China life sciences

Taking advantage of the growing healthcare industry requires great accessibility to life sciences companies and government support, as well as adherence to strict standards, says CBC’s Hans Kang.